V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190007793 | 190006828 | 1.75 | 72.2 | Palliative (P) | 2019-07-03 | 2019-07-10 | Cisplatin + Doxorubicin | N | Y | METHOTREXATE | 101727107 |
| 190007798 | 190006829 | 1.74 | 88.9 | 03 | 2019-08-03 | 2019-08-18 | Capecitabine + Oxaliplatin 21day | 02 | Y | NIRAPARIB | 100064495 |
| 190007803 | 190006830 | 1.73 | 59 | Neo-adjuvant (N) | 2021-03-23 | 2021-03-30 | CAPECITABINE + CARBOPLATIN + Cetuximab | 02 | null | FLUOROURACIL + OXALIPLATIN | 101777929 |
| 190007826 | 190006831 | 1.66 | null | Curative (C) | 2019-08-17 | 2020-02-04 | CTD (Thalidomide 100mg) | 02 | N | CABOZANTINIB | 100569318 |
| 190007827 | 190006832 | 1.8 | 83.8 | Curative (C) | null | 2020-12-18 | Carboplatin + Etoposide iv&po | null | null | CISPLATIN + GEMCITABINE | 101706184 |
| 190007845 | 190006833 | 1.62 | 58.4 | 03 | 2016-12-10 | 2016-12-11 | CARBOPLATIN | 02 | N | CARBOPLATIN | 101845431 |
| 190007852 | 190006834 | 0 | 41.6 | Curative (C) | null | 2017-08-09 | Cisplatin + Paclitaxel | 2 | N | EVEROLIMUS | 101143537 |
| 190007868 | 190006835 | 1.77 | 76 | Neo-adjuvant (N) | 2020-06-18 | 2020-06-29 | Cisplatin | 02 | Y | CISPLATIN | 101667864 |
| 190007891 | 190006836 | 1.89 | 68.5 | null | 2020-06-23 | 2020-11-05 | R CODOX M | 01 | N | CABOZANTINIB | 101622902 |
| 190007914 | 190006838 | 1.71 | 89.7 | Curative (C) | 2016-06-11 | 2016-06-11 | Capecitabine | 01 | Y | CISPLATIN + RT | 100957670 |
| 190007921 | 190006839 | 1.78 | 54.1 | Palliative (P) | 2021-04-18 | 2021-05-12 | Carboplatin AUC 6 - 10 | 01 | null | CARBOPLATIN | 100408763 |
| 190007926 | 190006840 | null | 57 | Curative (C) | 2019-10-09 | 2019-11-23 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101129410 |
| 190007940 | 190006841 | 0 | 40 | Palliative (P) | 2017-09-09 | 2017-09-09 | CYCLOPHOSPHAMIDE + THALIDOMIDE | null | null | GEMCITABINE | 100396252 |
| 190007951 | 190006842 | 1.55 | 95.35 | null | 2022-01-19 | 2022-02-09 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | CISPLATIN + RT | 100006144 |
| 190007959 | 190006843 | 1.51 | 102 | null | 2017-08-14 | 2017-08-21 | VAC | 02 | N | FLUOROURACIL + IRINOTECAN | 100937043 |
| 190007960 | 190006844 | 1.9 | 71.8 | Curative (C) | 2019-02-06 | 2019-02-08 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101631786 |
| 190007962 | 190006845 | 1.58 | 79 | Curative (C) | 2017-06-11 | 2017-11-16 | Ifosfamide 3g/m2 5 day | N | N | CARBOPLATIN + VINORELBINE | 101116804 |
| 190007975 | 190006846 | 0 | 18.8 | null | 2018-05-26 | 2018-10-26 | DACTINOMYCIN + CYCLO + VINCRISTINE | 02 | N | CARBOPLATIN + ETOPOSIDE | 100532757 |
| 190007991 | 190006847 | 1.92 | 73.8 | Curative (C) | 2018-12-12 | 2019-01-24 | NB 13 cis-RA (Isotretinoin) | N | N | CISPLATIN + RT | 100804907 |
| 190007993 | 190006848 | null | 66.6 | null | null | 2017-03-25 | EW EuroEwing 2012 Arm A/B Zol Acid | 02 | null | CARBOPLATIN + ETOPOSIDE | 100526904 |
| 190007995 | 190006849 | null | 92.8 | null | 2016-12-09 | 2017-01-26 | Carboplatin AUC 2 - 5 | N | N | CARBOPLATIN | 100721617 |
| 190008029 | 190006850 | 1.57 | 88 | Palliative (P) | null | 2018-05-04 | Doxorubicin + Methotrexate | null | null | IRINOTECAN + MDG | 100040443 |
| 190008048 | 190006852 | 1.78 | 99.2 | Palliative (P) | 2021-04-23 | 2021-05-07 | Cisplatin | 02 | N | CISPLATIN | 101836772 |
| 190008059 | 190006853 | 0 | 11.8 | Curative (C) | 2022-04-05 | 2022-04-10 | Cisplatin + Radiotherapy | N | N | TRIAL UNSPECIFIED | 101539614 |
| 190008062 | 190006854 | 0 | 52 | Palliative (P) | null | 2020-10-29 | Cisplatin + Paclitaxel | 02 | null | BEVACIZUMAB | 100509524 |
| 190008067 | 190006855 | 0 | 38.8 | Palliative (P) | 2017-10-28 | 2017-11-09 | NB HRNBL-1 BUMEL MAT | 02 | null | NIVOLUMAB | 100253779 |
| 190008069 | 190006856 | 1.73 | 88.3 | null | 2021-09-06 | 2021-09-06 | CARBOPLATIN + RT | N | N | CARBOPLATIN | 100075619 |
| 190008073 | 190006857 | null | 36.3 | null | 2022-03-24 | 2022-03-25 | Atezolizumab | 01 | Y | CARBOPLATIN + ETOPOSIDE | 101006586 |
| 190008079 | 190006858 | 1.85 | 84.1 | Curative (C) | 2020-02-07 | 2020-05-13 | NIVOLUMAB | 02 | Y | ABEMACICLIB + FULVESTRANT | 101186131 |
| 190008082 | 190006859 | 1.7 | 91 | Neo-adjuvant (N) | 2021-09-12 | 2021-10-10 | Oxaliplatin + Modified de Gramont | null | null | CISPLATIN + RT | 101487489 |
| 190008095 | 190006860 | 1.73 | 64.1 | Palliative (P) | 2020-05-29 | 2020-05-31 | Cisplatin | 01 | N | CISPLATIN | 101435488 |
| 190008101 | 190006861 | 1.65 | 48 | null | null | 2019-07-17 | NB HRNBL-1 Isotretinoin | 02 | Y | LANREOTIDE | 100415829 |
| 190008110 | 190006862 | 1.67 | 72.8 | 03 | 2018-05-04 | 2018-05-20 | DACTINOMYCIN + IFOSFAMIDE + MESNA + VINCRISTINE | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100257695 |
| 190008131 | 190006863 | 1.71 | 54 | null | 2019-07-06 | 2020-01-13 | EW EuroEwing 2012 Arm A VAI | 02 | N | IPILIMUMAB + NIVOLUMAB | 100286973 |
| 190008135 | 190006864 | 1.54 | 29.5 | Adjuvant (A) | 2020-08-17 | 2021-01-27 | Cisplatin 7 day | 02 | N | CISPLATIN | 100764551 |
| 190008146 | 190006865 | 1.76 | 97.9 | Palliative (P) | 2018-09-28 | 2018-09-28 | EW EuroEwing 2012 Arm A VAI | 02 | N | CISPLATIN + FLUOROURACIL | 101233068 |
| 190008148 | 190006866 | 1.74 | 98.3 | Palliative (P) | 2020-06-22 | 2020-07-08 | EW EuroEwing 2012 Arm B VDC | 01 | N | CARBOPLATIN + GEMCITABINE | 100640897 |
| 190008159 | 190006867 | 0 | 25.3 | Palliative (P) | 2019-07-27 | 2020-01-14 | EOX | 02 | Y | CAPECITABINE + MITOMYCIN | 101102286 |
| 190008170 | 190006868 | null | 59.8 | Neo-adjuvant (N) | 2017-10-27 | 2017-12-22 | Doxorubicin + Olaratumab | N | N | FLUOROURACIL + OXALIPLATIN | 101093495 |
| 190008184 | 190006869 | 1.8 | 66.9 | Curative (C) | 2016-09-07 | 2016-09-14 | CISPLATIN + EPIRUBICIN | 02 | N | FLUOROURACIL + OXALIPLATIN | 100306595 |
| 190008187 | 190006870 | 1.83 | 35 | Curative (C) | 2018-01-17 | 2018-02-02 | EW EuroEwing 2012 Arm A VAI | 02 | null | DOCETAXEL | 100655437 |
| 190008208 | 190006871 | 0 | 47.4 | 03 | 2018-06-06 | 2018-06-14 | CAPECITABINE + IRINOTECAN | 02 | N | PACLITAXEL | 101616902 |
| 190008214 | 190006872 | 1.73 | null | Curative (C) | 2019-02-08 | 2019-03-02 | EW EuroEwing 2012 Arm A VAI | 01 | N | CAPECITABINE + IRINOTECAN | 101290738 |
| 190008218 | 190006873 | 1.64 | 43.4 | Curative (C) | 2021-04-29 | 2021-05-21 | EW EuroEwing 2012 Arm A VAC | 01 | null | CETUXIMAB | 101377729 |
| 190008223 | 190006874 | 1.69 | 106.3 | Neo-adjuvant (N) | 2016-12-27 | 2016-12-27 | CarboPEC-Taxol | Y | N | CETUXIMAB + RT | 100530594 |
| 190008242 | 190006875 | 1.9 | 109 | Curative (C) | 2018-03-17 | 2018-04-12 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | CISPLATIN + GEMCITABINE | 101555265 |
| 190008247 | 190006876 | 1.69 | 71 | Curative (C) | 2021-03-25 | 2021-09-26 | VAC | null | null | CAPECITABINE + CARBOPLATIN | 100608967 |
| 190008264 | 190006877 | 1.74 | 63 | Palliative (P) | null | 2018-08-06 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100399288 |
| 190008265 | 190006878 | 1.71 | 53.7 | Adjuvant (A) | 2018-09-21 | 2018-09-28 | NB HRNBL-1 COJEC Ind COURSE C | 01 | N | BLEOMYCIN | 101201661 |
| 190008267 | 190006879 | 1.8 | 64 | 03 | 2018-02-20 | 2018-02-27 | CAPECITABINE + IRINOTECAN | Y | N | TRIAL UNSPECIFIED | 101471565 |